Structural insights into an atypical secretory pathway kinase crucial for Toxoplasma gondii invasion by Lentini, Gaëlle et al.








Structural insights into an atypical secretory pathway kinase crucial for
Toxoplasma gondii invasion
Lentini, Gaëlle ; Ben Chaabene, Rouaa ; Vadas, Oscar ; Ramakrishnan, Chandra ; Mukherjee,
Budhaditya ; Mehta, Ved ; Lunghi, Matteo ; Grossmann, Jonas ; Maco, Bohumil ; Visentin, Rémy ;
Hehl, Adrian B ; Korkhov, Volodymyr M ; Soldati-Favre, Dominique
Abstract: Active host cell invasion by the obligate intracellular apicomplexan parasites relies on the
formation of a moving junction, which connects parasite and host cell plasma membranes during entry.
Invading Toxoplasma gondii tachyzoites secrete their rhoptry content and insert a complex of RON
proteins on the cytoplasmic side of the host cell membrane providing an anchor to which the parasite
tethers. Here we show that a rhoptry-resident kinase RON13 is a key virulence factor that plays a
crucial role in host cell entry. Cryo-EM, kinase assays, phosphoproteomics and cellular analyses reveal
that RON13 is a secretory pathway kinase of atypical structure that phosphorylates rhoptry proteins
including the components of the RON complex. Ultimately, RON13 kinase activity controls host cell
invasion by anchoring the moving junction at the parasite-host cell interface.
DOI: https://doi.org/10.1038/s41467-021-24083-y






The following work is licensed under a Creative Commons: Attribution 4.0 International (CC BY 4.0)
License.
Originally published at:
Lentini, Gaëlle; Ben Chaabene, Rouaa; Vadas, Oscar; Ramakrishnan, Chandra; Mukherjee, Budhaditya;
Mehta, Ved; Lunghi, Matteo; Grossmann, Jonas; Maco, Bohumil; Visentin, Rémy; Hehl, Adrian B;
Korkhov, Volodymyr M; Soldati-Favre, Dominique (2021). Structural insights into an atypical secretory
pathway kinase crucial for Toxoplasma gondii invasion. Nature Communications, 12(1):3788.
DOI: https://doi.org/10.1038/s41467-021-24083-y
ARTICLE
Structural insights into an atypical secretory
pathway kinase crucial for Toxoplasma gondii
invasion
Gaëlle Lentini 1,8, Rouaa Ben Chaabene 1,8, Oscar Vadas 1,8, Chandra Ramakrishnan 2,
Budhaditya Mukherjee 1,7, Ved Mehta 3, Matteo Lunghi1, Jonas Grossmann4,5, Bohumil Maco 1,
Rémy Visentin 1, Adrian B. Hehl2, Volodymyr M. Korkhov 3,6✉ & Dominique Soldati-Favre 1✉
Active host cell invasion by the obligate intracellular apicomplexan parasites relies on the
formation of a moving junction, which connects parasite and host cell plasma membranes
during entry. Invading Toxoplasma gondii tachyzoites secrete their rhoptry content and insert a
complex of RON proteins on the cytoplasmic side of the host cell membrane providing an
anchor to which the parasite tethers. Here we show that a rhoptry-resident kinase RON13 is a
key virulence factor that plays a crucial role in host cell entry. Cryo-EM, kinase assays,
phosphoproteomics and cellular analyses reveal that RON13 is a secretory pathway kinase of
atypical structure that phosphorylates rhoptry proteins including the components of the RON
complex. Ultimately, RON13 kinase activity controls host cell invasion by anchoring the
moving junction at the parasite-host cell interface.
https://doi.org/10.1038/s41467-021-24083-y OPEN
1Department of Microbiology and Molecular Medicine, University of Geneva, Geneva, Switzerland. 2 Institute of Parasitology, University of Zurich,
Zurich, Switzerland. 3 Institute of Biochemistry, ETH Zurich, Zurich, Switzerland. 4 Functional Genomic Center Zurich, ETH Zurich and University of Zurich,
Zurich, Switzerland. 5The Swiss Institute of Bioinformatics, SIB, Lausanne, Switzerland. 6 Paul Scherrer Institute, Villigen, Switzerland. 7Present address:
School of Medical Science and Technology, IIT Kharagpur, India. 8These authors contributed equally: Gaëlle Lentini, Rouaa Ben Chaabene, Oscar Vadas.
✉email: volodymyr.korkhov@psi.ch; dominique.soldati-favre@unige.ch













oxoplasmosis is a zoonotic infectious disease caused by the
protozoan parasite Toxoplasma gondii, a member of the
Apicomplexa phylum. Specialized apical secretory orga-
nelles called rhoptries and micronemes crucially participate in
gliding motility and active host cell entry of these obligate
intracellular parasites. Micronemes secrete surface-exposed
transmembrane adhesins (MICs) linked to the actomyosin sys-
tem that promote traction for motility and invasion. Rhoptries
inject proteins across the host cell plasma membrane (PM)1,
some acting as receptors during host cell invasion and others as
effectors to subvert host cellular functions2. These club-shaped
organelles contain rhoptry bulb proteins (ROPs) in the enlarged
base that are segregated from rhoptry neck proteins (RONs) at
the thin neck connected to the apical tip of the parasite. After
injection, the RON complex (composed of RON2, 4, 5, and 8) is
inserted in the host PM and binds to the microneme protein
AMA1 on the parasite surface, forming a multiprotein complex
that contributes to the formation of the moving junction (MJ)3,4.
On the host cytoplasmic side, the RON complex interacts with
several host adaptor proteins presumably linking the MJ with the
host cortical actin5. Powered by the parasite actomyosin system6,
the MJ translocates toward the posterior end of the invading
parasite, where the PM-derived parasitophorous vacuole mem-
brane (PVM) is sealed7,8. Of relevance, the rhoptries also dis-
charge membranous materials that participate in the PVM
formation9. Once inside the host cell, T. gondii tachyzoite
survival relies on an expanded coccidian lineage-specific family
of secreted ROP kinases and pseudo-kinases (ROPKs)10,11 acting
as key virulence factors12. The RON complex is heavily
phosphorylated13; however, the functional relevance of this
posttranslational modification and the kinase(s) implicated are
not known. Here, we identified and characterized a rhoptry-
resident kinase RON13 that phosphorylates several rhoptry
proteins, including the RON complex. RON13 kinase activity
stabilizes the RON complex at the MJ to ensure successful
invasion.
Results
Proteolytic maturation of RON13. Most ROPs/RONs as well as
MICs are synthetized as pre-pro-proteins and are processed in
the endosomal-like compartment by the aspartyl protease ASP3
ref. 14. ASP3-depleted parasites are unable to invade host cells,
notably due to a severe defect in rhoptry discharge. Among the
identified ASP3 substrates14 the TGGT1_321650 gene product
(here referred to as RON13) is predicted to be a kinase. RON13
localizes to the rhoptry neck14 and deletion of the gene is fitness-
conferring based on a genome-wide CRISPR-Cas9 screen15.
Ultrastructure expansion microscopy (U-ExM) revealed that
RON proteins present two types of localizations, previously
undistinguishable by conventional microscopy. RON2 and RON4
are found all along the neck of the organelles, while RON13 and
RON9 localize at the extreme tip of the rhoptry neck (Fig. 1a and
Supplementary Fig. 1a, b). Upon ASP3 depletion, the localization
of RON13 and other RONs is altered with a disappearance of the
neck and sliding of the bulbous part of the organelle closer to the
conoid (Fig. 1a and Supplementary Fig. 1a, b). Focused ion beam
scanning electron microscopy (FIB-SEM) analysis confirmed that
the rhoptry necks are morphologically aberrant and do not
extend to the apical tip of the parasite (Fig. 1b, Supplementary
Fig. 1b, and Supplementary Movies 1 and 2). RON13 is a sub-
strate of ASP3 and consequently, in the absence of the protease,
RON13 is not processed anymore and accumulates as a mem-
brane-anchored, largely insoluble pro-protein (Fig. 1c, d and
Supplementary Fig. 1c). Taken together the aberrant rhoptry
morphology and content organization in ASP3-depleted parasites
provide a rationale for the previously reported defect in rhoptry
discharge14 (Fig. 1e).
The topology of the RON13 at the rhoptry membrane was
examined in RON13-YFP-expressing parasites. Processed RON13
localizes to the rhoptry lumen as demonstrated by the lack of
detection of RON13-YFP by cytosolic anti-YFP nanobodies
(Fig. 2a and Supplementary Fig. 2a). To determine if RON13 is
secreted, RON13 was fused to beta-lactamase (RON13-BLA) and
intracellular lactamase activity was used as a sensitive readout for
rhoptry secretion in the host cell16. Cells infected by RON13-BLA
parasites do not show any detectable lactamase activity (Fig. 2b–e
and Supplementary Fig. 2b–e). In addition, RON13 is neither
associated with e-vacuoles nor with the RON complex post-
secretion in invading parasites, supporting the notion that
RON13 is not secreted into the host cell during invasion but is
instead active in the parasite (Supplementary Fig. 2f, g).
RON13 is an active kinase. RON13 is a 153 kDa type II trans-
membrane protein with a putative serine/threonine kinase
domain and a large luminal carboxy-terminal extension (CTE)
with no identifiable structural motif (Fig. 1d). Phylogenetic ana-
lysis showed that RON13 belongs to the ROPK clade (Supple-
mentary Fig. 3)11. It has a bilobal kinase domain organization and
possesses the motifs characteristic of active eukaryotic protein
kinases (ePKs; Supplementary Data. 1). The canonical HRD
catalytic triad of ePKs differs in RON13 with an HFD motif
conserved among all the coccidian orthologues of RON13 (Sup-
plementary Data 2). RON13 is an active kinase as demonstrated
by the intense autophosphorylation activity of the recombinant
RON13 protein (rRON13k; Fig. 3a–c). The kinase activity is sti-
mulated by the addition of Mg2+ or Mn2+, and is insensitive to
the broad-spectrum kinase inhibitor staurosporine (Fig. 3c),
similarly to the Fam20C secretory pathway kinase17. In addition,
ATP hydrolysis activity was detected (Fig. 3d). The catalytic
activity was completely abolished by introducing a single amino
acid change (D595A) in the catalytic HFD motif (rRON13dk),
validating the importance of this conserved kinase motif for
enzymatic activity (Fig. 3a–c).
RON13 has an atypical kinase structure. To gain insight into the
function and regulation of RON13 kinase, its three-dimensional
structure was resolved at 3.1 Å resolution by single-particle cryo-
EM (Fig. 4a, Supplementary Fig. 4a–i, Supplementary Table 1,
and Supplementary Movie 3). The RON13 kinase domain is
similar to ePKs, but contains an α-helical N-lobe insertion (NLI;
Fig. 4b, c) present exclusively in RON13 coccidian orthologues
(Supplementary Data 1 and 2). Unlike ROPKs that also reside in
the rhoptries, RON13 lacks an α-helical N-terminal extension
(Fig. 4d)10,18. The kinase C-lobe structure contains all the motifs
required for ATP transfer to the substrate, as well as a ROPK-
specific disulfide bond10. Another unique feature of RON13 is its
CTE, composed of 550 amino acids, that shares no sequence
homology with any other proteins (Supplementary Data 1 and 2).
The CTE is mainly composed of α-helices clamping the kinase
domain C-lobe (Fig. 4b). Of note, the CTE is essential for RON13
folding and stability as neither expression of the kinase domain
alone, nor proteolytic cleavage to separate the kinase domain
from the CTE of rRON13 yielded a functional RON13 kinase.
Although the proteolytic cleavage was efficient, as observed on
denaturing/reducing SDS–PAGE analysis, both the kinase
domain and the CTE remained attached and could not be sepa-
rated by addition of high salt concentrations. Cleaved rRON13
behaved exactly as WT rRON13 when analyzed by size-exclusion
chromatography, further emphasizing the strong interaction
between RON13 kinase domain and the CTE (Supplementary
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Fig. 5a, b). Analysis of RON13 electrostatic potential highlighted a
rather extended positively charged groove lying on one side of the
kinase that may be involved in protein–protein interactions, but
did not provide strong hints to the role the CTE plays (Supple-
mentary Fig. 5c).
RON13 is critical for invasion and virulence. To assess the role
of RON13 kinase in T. gondii, knockdown parasites (RON13-KD)
were generated by replacing the endogenous promoter with an
anhydrotetracycline (ATc) repressible promoter (Supplementary
Fig. 6a). The promoter swapping resulted in RON13 gene
knockdown even without ATc treatment (Supplementary Fig. 6b,
c). RON13-KD parasites were severely impaired in their lytic
cycle and in host cell invasion (Fig. 5a–c and Supplementary
Fig. 6d), but not affected in intracellular replication or egress from
host cells (Supplementary Fig. 6e, f). Despite numerous attempts,
a complete deletion of the gene could not be obtained. The kinase
activity is important for RON13 function as complementation
with the dead kinase mutant (RON13-KD/ron13dk) failed to fully
rescue the phenotype. In contrast to ASP3-iKD14, RON5-iKD19
or ARO-iKD20 parasites previously reported to be unable to
secrete their rhoptries, rhoptry discharge into the host cell was
unaffected in RON13-KD parasites, when assayed by empty
vacuole formation (e-vacuoles)9 or by ROP16-dependent host cell
STAT6 phosphorylation21 (Fig. 5d–g). Likewise, microneme
secretion was unaffected in RON13-depleted parasites (Fig. 5h).
These results indicate that the invasion defect of RON13-KD
parasites is not explained by a defect in rhoptry discharge. Of
note, infection with RON13-KD parasites resulted in a premature
damage of the host cell monolayer, a phenomenon not observed
with RON4-KO parasites that display otherwise a comparable
invasion defect (Fig. 5i, j and Supplementary Fig. 6g). Remark-
ably, RON13-KD parasites lost virulence in mice (Fig. 5k) along
with a failure to elicit a protective immune response (Supple-
mentary Fig. 6h and Supplementary Table 2). Such inability to
trigger immune protection has been previously reported in
mutant parasites defective in secretion of rhoptry contents20,22. In
contrast, RON13-KD/ron13dk parasites were avirulent, but still
able to induce seroconversion and protection in the infected
animals challenged with the lethal RH strain (Fig. 5k and Sup-
plementary Fig. 6h). Taken together, the presence of RON13
appears to favor host cell survival and is necessary to mount a
protective immune response.
RON13 phosphorylates mainly RONs. RON13 substrate iden-
tification was undertaken using comparative phosphoproteome
analyses of wt (RH) versus RON13-KD (dataset 1), as well as
RON13-KD/ron13wt versus RON13-KD/ron13dk (dataset 2;
Fig. 6a). A total of 14,681 phosphosites (mainly phosphoserines)










































































































Fig. 1 RON13 is a RON kinase processed by ASP3. a U-ExM images of rhoptries from ASP3-iKD/RON13-3Ty extracellular parasites ± anhydrotetracycline
(ATc). RON4 (green) and ROP2/3/4 (green) antibodies are used to visualize the neck and the bulb of the rhoptries, respectively. RON13-3Ty (magenta) is
detected by anti-Ty antibodies. The subpellicular microtubules (gray) are stained with α/β anti-tubulin antibodies. Scale bar= 2 µm. Image representative
of three biologically independent experiments. b 3D reconstruction from FIB-SEM images of the apical part of RH (control) and ASP3-iKD parasites treated
48 h with ATc. The neck (green) and the bulb (violet) of the rhoptries are colored. The conoid (black) and the PM (gray) are depicted. n= 1 biologically
independent experiment. c Solubility of RON13 in ASP3-iKD/RON13-3Ty parasites ±ATc. Catalase is a marker of the soluble fraction. Samples derived from
the same experiment and gels were processed in parallel. Image representative of three biologically independent experiments. d Scheme of RON13 protein
and its cleavage by ASP3 just downstream the transmembrane domain (TMD). S/T serine/threonine kinase domain (orange), CTE C-terminal extension
(gray). e Scheme representing the fate of RON13 in presence or in absence of ASP3. Without processing by ASP3, RON13 remains insoluble and
mistargeted to the body of morphologically aberrant rhoptries. ELC endosome-like compartment. Source data are provided as a Source data file.
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The overlap with a previous study13 is partial mainly due to dif-
ferences in sample size, as well as in the experimental settings. The
enrichment of phosphopeptides by immunoprecipitation done in
this study allowed the detection of low abundance peptides leading
to the identification of new phosphoproteins13 (Supplementary
Data 3 and Supplementary Fig. 7a, b). Over 220 phosphopeptides
corresponding to 171 phosphoproteins showed a >4-fold differ-
ence in abundance in wt compared to RON13-KD (dataset 1).
Dataset 2 revealed 196 differentially phosphorylated proteins

































































































































































































Fig. 2 RON13 is a luminal rhoptry protein that is not secreted during invasion. a IFAs of RH-, ARO-YFP- (green), RON11-YFP- (green), or RON13-YFP-
(green) expressing parasites transiently transfected with cytosolic nanobodies targeting YFP fused to a myc-tag (YFPnb-myc). ARO is a protein associated
with the cytosolic face of the rhoptry membrane and RON11 is a type III transmembrane protein with its C-terminal domain exposed in the parasite
cytoplasm. The myc signal (magenta) observed at the basal part of the parasite is unspecific. Left panels show the schematic topology of the proteins and
their ability to bind the cytosolic YFPnb-myc. Scale bar= 2 μm. Image representative of three biologically independent experiments. b Principle of the
experimental design for the FRET-based rhoptry secretion assay used to determine if RON13 (orange) is secreted into the host cell during the invasion.
Toxofilin (blue) is a soluble rhoptry protein secreted into the host cell. c Gating strategy for quantification of fluorescein+ cell (green gate; λ= 550 nm) and
coumarin+ cell (violet gate; λ= 450 nm) frequency for RON13-BLA- and Toxofilin-BLA-infected cell monolayer (yellow gate) analyzed by flow cytometry.
d, e Frequency of fluorescein+ cells (λ= 550 nm, d) or coumarin+ cells (λ= 450 nm, e) in each condition (mean ± SD; n= 3 biologically independent





























































































































Fig. 3 Recombinant RON13 is active in vitro. a Scheme of recombinant RON13 kinase (rRON13k) and RON13 dead kinase (rRON13dk), in which
kinase activity is abrogated by introducing the mutation D595A. b Coomassie-stained gel of purified rRON13k and RON13dk produced in insect cells.
c Radioactive RON13 kinase activity assays based on rRON13k autophosphorylation. Radiograph is shown below the graph. Densitometry data (mean ± SD;
n= 3 biologically independent experiments) were normalized to rRON13k in presence of Mn2+. Statistical significance was determined using a two-tailed
paired t test. STS staurosporine. d ATP hydrolysis during kinase reactions, as measured by TLC analysis (mean ± SD; n= 3 biologically independent
experiments). Autoradiograph showing both non-hydrolyzed ATP (ATP) and inorganic phosphate (Pi) is shown below the graph. P values were determined
by a two-tailed paired t test. Source data are provided as a Source data file.
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RON13-kD/ron13dk. Overall 42 proteins (63 phosphopeptides)
are common to both datasets (Fig. 6b, Supplementary Fig. 7c, and
Supplementary Data 4). We defined phosphopeptides as highly
probable targets of RON13, when these were upregulated in both
datasets, i.e., in wt versus RON-13KD, as well as RON13-KD/
ron13wt versus RON13-KD/ron13dk. According to the spatial
data obtained from hyper LOPIT23, most of the proteins hits are
predicted to localize to the rhoptries (Fig. 6c, d and Supplementary
Fig. 7d, e). Dataset 2 uncovered an increased phosphorylation of
proteins from microneme, apicoplast and inner membrane com-
plex likely attributable to the ~3-fold higher level of RON13 in
RON13-KD/ron13wt parasites compared to wt (Supplementary
Data 4). It is plausible that the overexpression of RON13 in the
RON13-KD/ron13wt parasites led to mis-trafficking and thus to
increased exposure of RON13 to targets outside of the rhoptries. A
large proportion of the deduced RON13 substrates consists of
previously annotated or predicted ROPs and RONs based on
fractionation or transcriptomic data23,24 (Supplementary Data 5).
Analysis of the phosphopeptide sequences led to the identification
of a RON13 substrate consensus motif ExxxxxExxxNxSQSSxx-
xAxE (Supplementary Fig. 7f).
Of interest, three autophosphorylation sites were identified on
RON13: Thr379 and Ser381 within the NLI in proximity to the
ATP-binding site (N-lobe) and Thr703 closer to the activation
loop (C-lobe; Fig. 7a, b). Mutation of these residues to alanine
(phosphonull mutant, ron13pn) abolishes autophosphorylation
in vitro, whereas mutation to aspartic acid (phosphomimetic
mutant, ron13pm) does not impact RON13 autophosphorylation,
suggesting that other residues than the ones identified are
targeted (Fig. 7c). The complemented RON13-KD/ron13pm
parasites showed a mild defect in invasion (Supplementary
Fig. 8a–c), suggesting a modest contribution of RON13 autopho-
sphorylation to its function. Taken together comparative
phosphoproteomics reveals that RON13 phosphorylates rhoptry
proteins in situ, including the components of the RON complex.
RON4 is a substrate of RON13. RON4 which plays a critical role
















RON13 kinase domain PKA ROP5B
d
N-term extension
Fig. 4 Structure of RON13. a Cryo-EM density map determined by single-particle analysis at a resolution of 3.1 Å (top), and the corresponding views of the
atomic model of rRON13dk. The kinase domain and the C-terminal extension (CTE) are colored in orange and gray tones. b Domain organization of RON13.
The position of the ATP-binding site is indicated by the ATP ligand modeled into the active site (absent in the experimentally determined density map). The
N-lobe insertion (NLI, red) and the C-terminal extension (CTE, gray) are color-coded. c Surface representation of RON13 kinase domain at 3.1 Å resolution.
d Comparison of RON13 kinase domain structure with other kinases. PKA from Mus musculus (PDB ID: 1atp) is complexed with MnATP and an inhibitory
peptide (violet). ROP5B from T. gondii bound to ATP (PDB ID: 3q60) contains a ROP-specific N-terminal extension (blue).
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Fig. 5 RON13 is critical for invasion. a Plaque assays of different parasite strains (±ATc) showing that depletion of RON13 impairs the parasite lytic cycle
(no plaque), a phenotype that is fully rescued by complementation with an active RON13 kinase. Image representative of three biologically independent
experiments. b Quantification of plaque assays for RH, RON13-KD, and complemented RON13-KD/ron13wt or RON13-KD/ron13dk parasites (±ATc). Data
are presented as box and whiskers plot (median with min to max, n= 3 biologically independent experiments). Statistical significance was assessed by a
two-way ANOVA significance with Tukey’s multiple comparison. c Invasion assay (+ATc) showing a strong invasion defect when RON13 kinase is absent
or inactive P value were determined by a one-way ANOVA significance with Tukey’s multiple comparison. (Mean ± SD; n= 3 biologically independent
experiments). d IFA showing a representative field of the rhoptry secretion test using phosphor-STAT6 as a readout with fibroblast nuclei stained in DAPI
(magenta) and ROP16-injected cells stained with anti-phospho-STAT6 (STAT6-P) antibody (green, asterisks). Scale bar= 25 μm. Image representative of
three biologically independent experiments. e Phospho-STAT6 assays assessing the ability of the parasite to secrete the rhoptry protein ROP16 into the
host cell that phosphorylates host STAT6 in the nucleus. Data are presented as box and whiskers plot (median with min to max, n= 3 biologically
independent experiments). Statistical significance was assessed by a two-way ANOVA significance with Tukey’s multiple comparison. f Representative IFA
of the e-vacuole assay to assess rhoptry secretion when invasion is blocked by cytochalasin D. A parasite (p) secreting e-vacuoles ROP1+ (asterisks) is
depicted. Parasite DNA is visualize using DAPI (blue). Scale bar= 5 µm. Image representative of three biologically independent experiments. g E-vacuole
assays assessing the ability of the parasites to secrete the rhoptry protein ROP1 into the host cell (mean ± SD; n= 3 biologically independent experiments).
Statistical significance was assessed by a one-way ANOVA significance with Tukey’s multiple comparison. h Microneme secretion of extracellular
parasites stimulated with 2% ethanol to assess the release of MIC2 in culture supernatant. pMIC2 processed MIC2, ESA excreted–secreted antigens. GRA1
is used as a control for constitutive secretion from dense granules. Samples derived from the same experiment and gels were processed in parallel. Image
representative of three biologically independent experiments. i Kinetic assay representing the cell index of HFF infected with different parasite strains.
(Mean ± SD; n= 3 biologically independent experiments). j Invasion assay showing that RON13-KD and RON4-KO parasites are defective in invasion.
P values were determined by a one-way ANOVA significance with Tukey’s multiple comparison (mean ± SD; n= 3 biologically independent experiments).
Statistical significance was assessed by a one-way ANOVA significance with Tukey’s multiple comparison. k Virulence of different strains in mice.
Surviving mice at 84 days post infection were challenged with RH parasites (gray shaded). (n= 5 biologically independent animals). P values were
determined by a Mantel–Cox test. Source data are provided as a Source data file.
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-021-24083-y
6 NATURE COMMUNICATIONS |         (2021) 12:3788 | https://doi.org/10.1038/s41467-021-24083-y | www.nature.com/naturecommunications
To validate it as a direct substrate, recombinant RON4 (rRON4)
produced in insect cells was purified and its phosphorylation by
rRON13 tested in vitro. Compared to the generic kinase substrate
myelin basic protein (MBP) or autophosphorylation,
rRON4 serves as a much better substrate, while maintaining the
same ion preferences as observed with autophosphorylation
(Fig. 7d, e), strongly suggesting that RON4 is an endogenous
substrate. The phosphorylation status of rRON13 clearly influ-
enced its RON4-directed phosphotransferase activity with the
phosphonull mutant (rRON13pn) showing a twofold increased
activity, whereas phosphomimetic significantly downregulating
RON4 phosphorylation status (Fig. 7c). Thus, RON13 autopho-
sphorylation directly influences substrate phosphorylation
in vitro. Next, hydrogen/deuterium eXchange-mass spectrometry
(HDX-MS)25 was applied to map the interaction sites between
RON13 with RON4. HDX-MS can monitor protein dynamics
based on the rate of exchange of protein amide protons with the
solvent. Comparison of rRON13 dynamics alone and in presence
of an excess of rRON4 (Fig. 7f) identified a single region pro-
tected from H/D exchange by RON4 (amino acids 377–390;
Fig. 7g, Supplementary Fig. 9a, b, Supplementary Data 6, and
Supplementary Table 3). As the only rRON13 region showing
differential HDX rate upon addition of RON4 is small compared
to the overall rRON13 structure, this suggests that the
RON13–RON4 interaction is transient. Of relevance, this region
is surface-exposed within the NLI and comprises two of the
autophosphorylation sites, Thr379 and Ser381 (Fig. 7h). These
results validate the direct interaction between rRON4 and
rRON13, and identify the NLI as a substrate-recognition region.
RON13-KD parasites are unable to assemble the MJ. As pre-
viously stated, the majority of RON13-KD parasites were defec-
tive in host cell entry and remained extracellular (~90%; Fig. 8a).
However, among the minor subpopulation of invading parasites,
the typical ring-shaped MJ was observed in <14% of the events
(Fig. 8b). For most of the RON13-KD- and RON13-KD/ron13dk-
invading parasites, the MJ components RON2/4/8 were absent or
abnormally distributed at the host–parasite interface (Fig. 8b, c).
Importantly, prior to secretion, the RON complex is properly
processed, assembled, and accurately targeted to the neck of the
rhoptries (Fig. 8d). Furthermore, co-immunoprecipitation
experiments of RON4 confirmed that the intact RON complex
is still able to associate to the microneme protein AMA1 (Fig. 8e
and Supplementary Table 4). Consequently, RON13-catalyzed














































































































































































































































































































































































































































Fig. 6 Rhoptry proteins are the major substrate of RON13. a Workflow of the shotgun approach and phosphoproteome analysis used to identify
RON13 substrates. Samples were prepared for each strain from four independent experiments (n= 4 biologically independent experiments). RH (blue)
RON13-KD (orange) RON13-KD/ron13wt (green) RON13-KD/ron13dk (salmon). b Venn diagrams of the phosphoproteins found in datasets 1 and 2. c Bar
graph showing the percentage of phosphoproteins from datasets 1 and 2 relative to the total number of phosphoproteins, according to their predicted
localization23. EM endomembrane, IMC inner membrane complex. d Polar plot of the number of phosphopeptides found in both datasets (common) binned
by gene IDs and clustered, according to their predicted subcellular localizations23. Source data are provided as a Source data file.
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the parasite/host interface without destabilizing the RON com-
plex prior secretion. Of note, autophosphorylation of RON13
does not influences the correct assembly of the RON complex at
the MJ post-secretion (Supplementary Fig. 10a, b). Identified as
an endogenous RON13 substrate, modification of RON4 phos-
phorylation status alone is not sufficient to prevent MJ formation.
Indeed, RON4 phosphonull (RON4pn) and RON4 phosphomi-
metic (RON4pm) mutant parasites (Fig. 9a–c) showed an unal-
tered lytic cycle and host cell invasion (Fig. 9d–f). In accordance
with these observations, in both RON4 phosphomutant parasites,
the stabilization of the RON complex at the MJ is unaffected and
even if dispensable, we observed the recruitment of the host
adaptor protein ALIX to the MJ5 (Fig. 9g–j). Overall, these results
suggest a pleiotropic role of RON13 in the phosphorylation of
each of the components of RON complex that together contribute
to the success of host cell invasion.
Discussion
RON13 is an atypical kinase possessing a unique NLI within the
kinase domain that participates in substrate recognition. It har-
bors a large CTE critical for proper folding that is conserved
among the coccidians. Comparisons of RON13 CTE structure to
other proteins in the protein data bank did not reveal any clear
match (only superficial similarity of the CTE fold to that of
cytochrome P450, OleP (PDB ID: 5mnv), could be detected using
PDBeFold26 (https://www.ebi.ac.uk/msd-srv/ssm/ssmcite.html)).
Based on this, the CTE region of RON13 bares little to no
structural similarity to any other proteins of known structure.
RON13 clusters with the ROPK family members but differs from
the ROPKs characterized to date. It localizes to the neck instead
of the bulb of the rhoptries and does not appear to be secreted,
although we cannot formally exclude it. Moreover, its kinase
activity is essential for parasite survival and with its insensitivity
to the broad kinase inhibitor staurosporine, it offers great pro-
mises for the identification of highly selective inhibitors. This
atypical kinase operates in the secretory pathway and phos-
phorylates predominantly RON proteins, but also other ROPs
known to be involved in subversion of host cell function.
The premature destruction of the HFF monolayer observed
under RON13-KD infection supports the hypothesis that this
kinase modulates the function of an unidentified secreted ROP
that controls host cell survival by an unknown mechanism.
Furthermore, infection of mice with RON13-KD parasites failed
to mount a resistance to reinfection. This phenomenon was
previously observed only in parasites incompetent in invasion,
resulting from defect in rhoptry discharge. Thus, RON13-
dependent phosphorylation of effectors likely participates in
modulation of host immune response. In contrast the impact of
RON13 on the RON complex is more evident. The phosphor-
ylation of the individual components of the RON complex is
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Fig. 7 RON4 is a direct substrate of RON13. a Partial view of the
RON13 structure highlighting the autophosphorylation sites (arrows, red).
Kinase domain (orange tones). NLI (N-lobe insertion). b Schematic
representation of RON13 structure organization highlighting the
autophosphorylated residues (red) mutated in this study. The kinase
domain and the C-terminal extension (CTE) are colored in orange and gray
tones. c Radioactive kinase activity assays comparing RON4
phosphorylation and RON13 autophosphorylation for different rRON13
phospho-mutants; phosphonull (RON13pn) and phosphomimetic
(RON13pm). Autoradiograph of a representative radioactive kinase assay is
shown below the graph. Data shown as mean ± SD normalized to wt (n= 3
biologically independent experiments). P values were determined using a
two-tailed paired t test. d Radioactive kinase activity assays characterizing
the influence of ions on rRON4 phosphorylation by RON13. Densitometry
data (mean ± SD; n= 3 biologically independent experiments) were
normalized to RON4 phosphorylation in presence of Mn2+. Statistical
significance was determined using a two-tailed paired t test.
e Autoradiograph from a radioactive kinase activity assays in presence of
MBP (left) or RON4 (right) as a substrate. f Schematic representation of
the two states analyzed by HDX-MS. The kinase domain and the C-terminal
extension (CTE) are colored in orange and gray tones. NLI (red). RON4
(violet). g Differences in HDX rates between rRON13dk alone and in the
presence of RON4. A single region encompassing amino acids 377–390 is
protected by RON4, indicating the contact site between the two proteins.
Data shown as mean ± SD; n= 3 biologically independent experiments.
h RON13 kinase domain highlighting the RON4-binding site (residues
377–390; blue) identified by HDX-MS. This region corresponds to the NLI
and encompasses the two phosphosites Thr379 and Ser381. Source data
are provided as a Source data file.
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the parasite–host interface and host invasion (Fig. 10). Mutations
in the known phosphorylated sites of RON4 were not sufficient to
recapitulate the phenotype observed in absence of RON13. This
result suggests a cooperative role of phorsporylation of RON2/4/5
and 8 for the proper assembly of the MJ at the host PM, as
observed for the interaction between RON complex and host
proteins5. This study unravels a new level of complexity in the
mechanism that governs invasion highlighting the phosphoryla-
tion as a key posttranslational modification that arms the secreted
virulence factors necessary for host cell invasion. RON13 is found
and conserved in the coccidian subgroup of the Apicomplexa.
Importantly, the components of the RON complex are also
phosphorylated in the deadliest malaria parasite Plasmodium
falciparum. In silico analysis identified a predicted atypical kinase
(PF3D7_3121100) expressed in the invasive stages of P. falci-
parum that also displays some homology to TgRON13, including
a large CTE and a determinant to enter the secretory pathway
(Supplementary Data 7). Such an atypical kinase is worthy of
deeper investigations as it might unravel a potential candidate for
targeting invasion in malaria parasites via chemotherapeutic
intervention.
Methods
DNA vector constructs and transfections. The sequence of the oligonucleotide
primers and the plasmids generated are listed in Supplementary Table 5. The T.
gondii ΔKU80 RH27 and TaTi/ΔKU80 (ref. 28) strains were used to obtain all the
transgenic strains generated in this study (Supplementary Table 5). Escherichia coli
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Fig. 8 RON13 kinase activity is important for moving junction formation during invasion. a Graph representing the proportion of extracellular, invading,
and intracellular parasites observed in the pulse-invasion assay. The scheme depicts the three stages of the invasion process considered in this assay
(mean ± SD; n= 3 biologically independent experiments). Statistical significance was assessed by a one-way ANOVA significance with Tukey’s multiple
comparison. b Quantification of the different types of RON2 and RON4 staining (absent, abnormal, and ring shaped) observed at the MJ of invading
parasites. (Mean ± SD; n= 3 biologically independent experiments). Statistical significance was assessed by a one-way ANOVA significance with Tukey’s
multiple comparison. c IFAs showing a representative example of RON2, RON4 and RON8 staining (green) of invading RON13-KD parasites obtained from
three biologically independent experiments. An arrow indicates the bona fide ring-shaped MJ. Anti-SAG1 (magenta) and anti-actin (blue) antibodies stain
the extracellular part of the parasite and the parasite cytoplasm, respectively. For the last row, anti-GAP45 antibodies (blue) were used. Scale bar= 2 µm.
d IFAs on RH and RON13-KD intracellular parasites showing that proteins of the RON complex are well expressed and addressed to the rhoptry in RON13-
KD-treated parasites. For the first row, RON5 is in magenta and RON9 in green. RON4, RON2, and RON8 are in green. Anti-ARO (magenta) and anti-
RON9 (magenta) antibodies are used as rhoptry compartment markers. Scale bar= 2 µm. Image representative of three biologically independent
experiments. eWB showing a comparable level of expression of RON complex proteins between RH and RON13-KD parasites using anti-RON2, anti-RON4,
and anti-RON5C antibodies. Actin (anti-ACT) is used as a loading control. Image representative of three biologically independent experiments. Source data
are provided as a Source data file.
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To generate RON13-3Ty transgenic parasites, 1763bp corresponding to the C-
terminal part of RON13 (TGGT1_321650) were amplified using the primers 6765/6766,
and cloned into the ApaI and SbfI sites of the vector Ct‐ASP5‐3Ty‐DHFR29. A total of
40 µg of Ct-RON13-3Ty-DHFR plasmid were linearized by BstBI prior transfection.
For the YFP C-term tagging of ARO and RON11, we amplified the 3′ coding
sequence of each gene using the primer pairs 8798/8799 (1043 bp) and 8800/8801
(1345 bp), respectively. PCR fragments were cloned into the LIC-YFP-DHFR
vector27 and the final vectors were digested with BclI for ARO-YFP-DHFR and
with AflII for RON11-YFP-DHFR, respectively, prior to transfection.
For YFP C-term tagging of RON13, we amplified the 3′ coding sequence using
two pairs of primers 8802/8803 and 8804/8805 (1135 bp) to introduce a silent
mutation, and thus generate an EcoRV restriction site used for LIC-RON13-YFP-
DHFR vector linearization.
To generate RON13-KD parasite line, we amplified a PCR fragment encoding
the TaTi trans-activator, the HXGPRT selection cassette and the TetO7S1
promoter from the vector 5′COR-pT8TATi1-HXtetO7S1myc30, using the primers
7013/7015 and KOD polymerase (Novagen, Merck). Primers 7013 and 7015 each
share 30 and 32 bp of homology with the 5′ end of RON13. A specific gRNA vector
generated by Q5 Hot Start site-directed mutagenesis kit (NEB) with the primers
4883/7012 on the vector template pSAG1::CAS9-GFPU6::sgUPRT31 was used to
direct the insertion of the PCR cassette by double homologous recombination at
the 5′ of the ron13 locus.
To generate RON4-KO parasites, a gRNA targeting the 5′ coding sequence of
RON4 was used to introduce a frameshift, resulting in RON4-KO. RON4 protein










































































































































































Fig. 9 Phosphorylation of RON4 is not required for MJ formation and ALIX recruitment. a Schematic representation of RON4 protein. Two repeats (R1
and R2) and five motifs (pink lines) known to be important for binding host cytoskeleton are present in the N-term of RON4. The number (1, 2, 3, and 4)
indicate the regions of RON4 known to be phosphorylated. The corresponding amino acid sequences and phosphorylated residues are indicated below in
pink. These amino acids have been mutated in alanine or negatively charged amino acid to generate RON4 phosphonull (ron4pn) and RON4
phosphomimetic (ron4pm) mutant parasites, respectively. b Western blot showing that RON4pn and RON4pm are properly expressed. RON4-KO
parasites have undetectable amount of RON4. Image representative of three biologically independent experiments. c IFA showing that mutation of
phosphorylated residues either in Ala (ron4pn) or in Asp (ron4pm) does not impact RON4 (green) targeting to the rhoptry neck. Scale bar= 2 µm. Image
representative of three biologically independent experiments. RON2 (magenta). d Plaque assay comparing the ability parasites to accomplish the lytic
cycle. Image representative of three independent experiments. e Quantification of the plaque assay experiment. Data are presented as box and whiskers
plot (median with min to max, n= 3 biologically independent experiments). Statistical significance was assessed by a one-way ANOVA significance with
Tukey’s multiple comparison. f Invasion test showing the percentage of intracellular parasites reflecting their ability to invade. One-way ANOVA followed
by Tukey’s multiple comparison was used to test differences between groups. (Mean ± SD; n= 3 biologically independent experiments). g IFA of invading
parasites with RON2 (green) and RON4 (green) seen at the MJ except for RON4-KO invading parasites. SAG1 (magenta) and GAP45 (blue) were used to
discriminate invading parasites. Scale bar= 1 µm. Image representative of three biologically independent experiments. h ALIX-GFP (green) expressing HeLa
cells infected by RH parasites (magenta). ALIX recruitment at the MJ closure is indicated by white arrowhead. The inset displays the white boxed area at
higher magnification. Scale bar= 5 µm. Image representative of three biologically independent experiments. i Quantification of the proportion of
intracellular parasites associated with an ALIX dot in an in/out assay. Data are presented as box and whiskers plot (median with min to max, n= 3
biologically independent experiments). Statistical significance was assessed by a one-way ANOVA significance with Tukey’s multiple comparison.
j Relative pixel intensity of ALIX dot recruited at the MJ in infected ALIX-GFP HeLa cells. When not stated two-way ANOVA followed by Tukey’s
multiple comparison was used to test differences between groups. (Mean ± SD; n= 3 biologically independent experiments). Source data are provided
as a Source data file.
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RON4pm and RON4pn parasites were generated by modifying the ron4
endogenous locus. Synthetic fragments corresponding to the bp 208 to bp 1104 of
the RON4 cDNA flanked by 100 bp of ron4 gDNA homology region in 5′ and 3′
and EcoRV restriction sites were purchased from Genewiz®. In those fragments,
the 23 phosphosites identified previously13 and in this study were mutated either to
alanine (ron4pn) or to acid aspartic (ron4pm). Following enzymatic restriction,
each fragment was co-transfected with the vector 2gRNA CRISPR-Cas9 plasmid32
containing 2gRNA targeting sequences located at 958 and 2519 bp from the start
codon (Supplementary Table 5). Parasite clones were selected by FACS and
screened by PCR for integration. The modified region was verified by sequencing.
To complement the RON13-KD line with a wild-type copy of ron13 under a
rhoptry promoter (pron5), total RNA was extracted from RH tachyzoites using the
RNeasy Minikit (Qiagen), and reverse transcribed in cDNA using the Superscript II
kit (Invitrogen). The specific full-length cDNA of ron13 gene was PCR-amplified in
three parts using the primers 8178/7813 (part 1—2097 bp), 7814/7815 (part 2—
960 bp), 7816/8179 (part 3—1152 bp), and the Pangea polymerase (Canvax).The
three fragments were Gibson assembled with the vector pUPRT-promRON5-G13-
4myc5 digested by PacI/EcoRV. A total of 60 µg of the resulting vector pUPRT-
pRON5-RON13-4myc was digested by KpnI/BamHI and co-transfected with 15 µg
of the pU6-Cas9-Universal-gRNAUPRT vector33. Parasites for which the
integration of the vector pUPRT-pron5-RON13-4myc at the UPRT locus by double
homologous recombination had occurred were selected by 5′-fluo-2′-deoxyuridine
(FUDR) negative selection and designated as RON13-KD/ron13wt. Point
mutagenesis introduced by Q5 site-directed mutagenesis (NEB) on pron5-RON13-
4myc were used to generate ron13dk, ron13cte, ron13pn, and ron13pm vectors
(Supplementary Table 5).
To assess RON13 secretion into the host cell, we modified the vector SP3-
toxofilin-BLA (kind gift from Dr. Lodoen MB.)16 by cloning RON13 cDNA in
frame with the beta-lactamase tag. The fragment pron5-RON13-4myc (5565 bp)
was PCR-amplified with the pair of primers 8263/8264 using the FastPangea
polymerase (Canvax), and subconed in the SP3-toxofilin-BLA vector previously
digested with SfoI and HindIII. The resulting construct was sequence verified and
transfected in RH parasites. Transgenic parasites were selected by addition of
hypoxanthine and mycophenolic acid.
Parasite culture. Tachyzoites from parental and modified strains were propagated
in confluent human foreskin fibroblasts (HFFs) with Dulbecco modified Eagle’s
medium supplemented with 5% fetal bovine serum, 2 mM glutamine, and 25 µg/
mL gentamicin. To generate transgenic parasites, 20 μg of linearized plasmid or of
PCR product were transfected with a mix of 15 µg Cas9‐sgRNA plasmid. Trans-
genic parasites were selected by addition of mycophenolic acid (25 µg/mL) and
xanthine (50 µg/mL) exploiting the HXGPRT selection cassette, 1 µM of pyr-
imethamine for the DHFR selection cassette, and 5 µM of FUDR for the negative
selection at the UPRT locus. Clones were isolated by limiting dilution or FACS and
checked for proper integration by immunofluorescence (Supplementary Table 6),
western blotting (Supplementary Table 6), and PCR on genomic DNA (Supple-
mentary Table 5) using the GoTaq polymerase (Promega). ATc treatment were
done for 48 h at 1 µg/mL. For treatment with 49c, infection was performed in the
presence of 1 µM of 49c and parasites were collected 48 h post infection.
Western blotting. Freshly egressed tachyzoites were pelleted by centrifugation,
washed with PBS, and resuspended in SDS–PAGE buffer (50 mM Tris-HCl, pH 6.8,
10% glycerol, 2 mM EDTA, 2% SDS, 0.05% bromophenol blue, and 100 mM
dithiothreitol (DTT)). After boiling and sonication, samples were subjected to
SDS–PAGE under reducing conditions. Proteins were transferred to nitrocellulose
membrane and immunoblot analysis was performed. Primary antibodies (Sup-
plementary Table 6) were diluted in 5% milk/0.05% Tween-20/PBS. Secondary
antibodies coupled with HRP were purchased from Invitrogen® and were used
according to manufacturer information. All western blots were done in triplicate.
Uncropped and unprocessed western blot can be found in the Source data file of
this manuscript.
Immunoprecipitation of RON4 and analysis by mass spectrometry. Freshly
egressed parasites RH and RON13-KD from a 10 cm dish were centrifuged, rinsed
in PBS, and lysed in PBS-1%Triton X-100 in the presence of protease and phos-
phatase inhibitors (PhosSTOP™, Roche®, and A32965, ThermoFisher®). Following
five cycles of freeze/thaw, the lysate was sonicated, incubated 10 min on ice, and the
soluble fraction was incubated with 10× concentrated supernatant containing
RON4 mAb 4H1 overnight. The next day protein A-sepharose equilibrated in IP
buffer was added and the incubation was continued for 1–2 h at 4 °C. Beads were
then washed three times in IP buffer, two times in PBS, resuspended in SDS–PAGE
sample buffer, and boiled. Sample were then loaded on a polyacrylamide gel and
directly upon entry in the separating gel, migration was stopped and bands were
cut, and submitted to the Proteomic Core Facility, Faculty of Medicine, Geneva.
To prepare the samples, bands of interest were digested as follow: gel pieces
were destained by incubation in 100 μL of 50% acetonitrile (AcN) in 50 mM
ammonium bicarbonate (AB) for 15 min at room temperature. Proteins were
reduced by incubation of gel pieces for 30 min at 50 °C in 100 μL of 10 mM DTT in
50 mM AB. DTT solution was then replaced by 100 μL of 55 mM iodoacetamide in
50 mM AB, and protein were alkylated by incubation of the gel pieces for 30 min at
37 °C in the dark. Gel pieces were then washed for 15 min with 100 μL of 50 mM
AB and for 15 min with 100 μL of 100% AcN. Gel pieces were then air dried for
15 min at room temperature. Dried pieces of gel were rehydrated for 45 min at 4 °C
in 35 μL of a solution of 50 mM AB containing trypsin at 10 ng/μL and 0.01% of
Protease Max Surfactant trypsin enhancer (Promega). Subsequently, 10 μL of 0.01%
of Protease Max in 50 mM AB was added before incubating the samples for 1 h at
50 °C. Supernatant was transferred to a new polypropylene tube and an additional
peptide extraction was performed with 70 μL of 20% FA for 15 min at room
temperature with occasional shaking. Extractions were pooled, completely dried
under speed vacuum, and stored at −20 °C.
For ESI-LC-MSMS, samples were diluted in 15 μL of loading buffer (5%
CH3CN and 0.1% FA) and 2 μL were injected on column. LC-ESI-MS/MS was
performed on a Q-Exactive Plus Hybrid Quadrupole-Orbitrap Mass Spectrometer
(Thermo Fisher Scientific) equipped with an Easy nLC 1000 liquid
chromatography system (Thermo Fisher Scientific). Peptides were trapped on a
Acclaim pepmap100, C18, 3 μm, 75 μm× 20 mm nano trap column (Thermo
Fisher Scientific) and separated on a 75 μm× 250 mm, C18, 2 μm, 100 Å Easy-
Spray column (Thermo Fisher Scientific). The analytical separation was run for 90
min using a gradient of H2O/0.1% formic acid (solvent A) and CH3CN/0.1%














































































Fig. 10 Cartoon summarizing the main findings. Left: in the endosome-like compartment (ELC) where protein trafficking to secretory organelles is
determined, Asp3 protease cleaves the N-terminal transmembrane segment of RON13. Rhoptry proteins, including RONs and ROPs (violet tones), are
phosphorylated by RON13 within this compartment. Center: RON13-phosphorylated proteins assemble to form the RON complex within the rhoptry neck,
prior to being secreted into the host. Right: the RON complex, localized to the cytosolic face of the host, contributes to parasite invasion by forming a
moving junction by associating with adhesins at the parasite plasma membrane (blue). Phosphorylated proteins of the RON complex additionally recruit
host proteins (green) to assist in parasite invasion and subvert host cellular functions.
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-021-24083-y ARTICLE
NATURE COMMUNICATIONS |         (2021) 12:3788 | https://doi.org/10.1038/s41467-021-24083-y | www.nature.com/naturecommunications 11
then to 65% A and 35% B for 60 min, then to 10% A and 90% B for 10 min, and
finally stay 15 min at 10% A and 90% B. Flow rate was of 250 nL/min for a total run
time of 90 min. For MS survey scans, the resolution was set to 70,000 and the ion
population was set to 3 × 106 with an m/z window from 400 to 2000. For data-
dependant analysis, up to 15 precursor ions were isolated and fragmented by
higher-energy collisional dissociation HCD at 27% normalized collision energy
(NCE). For MS/MS detection, the resolution was set to 17,500, the ion population
was set to 1 × 105 with an isolation width of 1.6m/z units. Peak lists (MGF file
format) were generated from raw data using the MSConvert conversion tool from
ProteoWizard. The peaklist files were searched against the ToxoDB_Tgondii_GT1
database (http://ToxoDB.org, release 42, 8460 entries) combined with an in-house
database of common contaminant using Mascot (Matrix Science, London, UK;
version 2.5.1). Trypsin was selected as the enzyme, with one potential missed
cleavage. Precursor ion tolerance was set to 10 p.p.m. and fragment ion tolerance to
0.02 Da. Carbamidomethyl of cysteine was specified as fixed modification.
Deamidation of asparagine and glutamine, and oxidation of methionine were
specified as variable modifications. The Mascot search was validated using Scaffold
4.9.0 (Proteome Software). Peptide identifications were accepted if they could be
established at >5.0% probability to achieve an false discovery rate (FDR) < 0.1% by
the Peptide Prophet algorithm34 with Scaffold delta-mass correction. Protein
identifications were accepted if they could be established at >26.0% probability to
achieve an FDR < 1.0 % and contained at least two identified peptides. Protein
probabilities were assigned by the Protein Prophet algorithm35. Proteins that
contained similar peptides and could not be differentiated based on MS/MS
analysis alone were grouped to satisfy the principles of parsimony. The mass
spectrometry proteomics data have been deposited to the ProteomeXchange
Consortium via the PRIDE36 partner repository with the dataset identifier
PXD021516.
Plaque assay. Confluent HFF monolayers were inoculated with freshly egressed
parasites in absence or presence of ATc. Seven days post infection, the infected cells
were fixed with 4% paraformaldehyde (PFA) and stained with a crystal violet
(Sigma). Lysis plaque area were quantified using ImageJ software (NIH, version
1.53c). Ten lysis plaque were quantified for each strain in each replicate. Quanti-
fication represents the mean (±SD) from three independent experiments. Statistical
significance was assessed by one-way ANOVA significance test with Tukey’s
multiple comparison on GraphPad Prism 8 software.
Intracellular growth assay. Freshly egressed parasites pretreated ±ATc for 24 h
were used to infect new confluent HFF on glass coverslips. Cells were fixed 24 h
post infection and parasite were visualized using anti-GAP45 antibodies by IFA.
For each condition, at least 200 vacuoles were counted. Experiments were per-
formed in three independent replicates. Results are presented as mean ± SD. Two-
way ANOVA followed by Tukey’s multiple comparison was used to test differences
between groups on GraphPad Prism 8 software.
Egress assay. Freshly egressed parasites pretreated ±ATc for 12 h were used to
infect new confluent HFF on glass coverslips. Cells were fixed 30 h post infection
and parasite boundaries were visualized using anti-GAP45 antibodies by IFA. At
least 200 vacuoles were counted. Results are presented as mean ± SD and the
experiment performed in three independent replicates. Two-way ANOVA followed
by Tukey’s multiple comparison was used to test differences between groups on
GraphPad Prism 8 software.
Microneme secretion. Freshly egressed RH and RON13-KD parasites were
resuspend in harvested and resuspended in intracellular buffer (5 mM NaCl, 142
mM KCl, 1 mM MgCl2, 2 mM EGTA, 5.6 mM glucose, and 25 mM HEPES, pH
7.5) ± ethanol 2%. After an incubation for 30 min at 37 °C, parasites were pelleted
and washed once with PBS, while the supernatant was cleared again by a second
centrifugation. Pellet and supernatant (excreted–secreted antigens—ESA) were
resuspend in sample buffer before boiling and immunoblotting. MIC2 secretion
and processing was assessed by western blotting. GRA1 is used as a marker for
constitutive secretion and catalase as a positive control of parasite lysis. This
experiment as done in triplicate.
Rhoptry secretion by e-vacuole assay. Freshly egressed parasites were washed
once with PBS, resuspended in prechilled egress buffer containing 1 µM cytocha-
lasin D, and incubated 10 min on ice. Then, the parasites were added to prechilled
HFFs. After a short centrifugation and 20 min on ice to allow the parasites to settle,
HFFs were washed with cold PBS. The PBS was replaced by warm media+
cytochalasin D. Rhoptry secretion was triggered by incubating the infected cov-
erslips at 37 °C for 20 min. The coverslips were then fixed with PFA 4%.
Approximately 100 parasites were counted in duplicate in three independent
experiments. Results are presented as mean ± SD and the statistical analysis was
done using one-way ANOVA statistical test on GraphPad Prism 8 software.
Rhoptry secretion by phospho-STAT6. Freshly egressed parasites (5 × 105) pre-
treated ±ATc for 48 h were used to infect HFF-coated coverslips. Following a short
centrifugation (30 s at 1100 × g) and an incubation on ice for 20 min, the cells were
incubated at 37 °C for 20 min and fixed with ice-cold methanol. After blocking,
immune-detection was performed using anti-phospho-STAT6 antibody (Cell sig-
naling 9361; 1/400). The experiments were done in triplicate and >200 host cell
nuclei were counted each time. P values were calculated using a two-way ANOVA
test on GraphPad Prism 8 software. The line represents the median and the
whiskers represent the min to max values from 30 fields.
Red/green invasion assay. Freshly egressed parasites were allowed to invade a
HFF for 30 min before fixing with PAF/Glu for 7 min. A first immune-detection
using anti-SAG1 antibodies on non-permeabilized cells was performed. Cells were
then fixed with 1% formaldehyde/PBS for 7 min, washed with PBS, and permea-
bilized using 0.2% Triton X-100/PBS. Parasites were labeled using anti-GAP45
antibodies. At least 100 parasites were counted in duplicate for each strain in three
independent experiments. Results are presented as mean ± SD, and the statistical
analysis was done using one-way ANOVA followed by Tukey’s multiple com-
parisons on GraphPad Prism 8 software.
In/out assay and moving junction formation. Freshly egressed parasites were
resuspended in cold DMEM and added to prechilled HFF monolayer on a glass
coverslip. Following a quick centrifugation (30 s at 500 × g) and an incubation of
20 min on ice, the culture was incubated at 38 °C for 3 min in a water bath and
fixed with PFA for 15 min. A first indirect immuno-detection using anti-SAG1
antibodies, and secondary antibodies was done followed by another fixation step
with 1% formaldehyde/PBS for 7 min and permeabilization with 0.025% saponin
for 10 min. After blocking, a second immuno-detection with anti-RON2, or anti-
RON4 or anti-RON8 antibodies was performed. Finally, cells were permeabilized
with 0.2%Triton X-100/PBS and stained with anti-GAP45 or anti-actin antibodies.
Extracellular parasites (SAG1+/GAP45+), in/out (half SAG1+/GAP45+; half
GAP45+), and intracellular parasites (GAP45+) were quantified. RON2 and
RON4 staining at the MJ was examined for at least 100 parasites. Values represent
means ± SD, from three independent assays. P values reported are from two-way
ANOVA statistical analysis followed by Tukey’s multiple comparison on GraphPad
Prism 8 software.
ALIX recruitment. The recruitment of ALIX at the MJ was assessed by quantifying
ALIX-positive staining at the site of invasion5. HeLa cells (0.8 × 105) were seeded
on glass coverslips and transfected after 24 h with 500 ng of ALIX-GFP plasmid
(kind gift from Dr. M. Lebrun) using lipofectamine 2000® (ThermoFisher),
according to the manufacturer’s protocol. The following day, in/out assays were
performed and cells were fixed with methanol and processed for IFA using anti-
GFP and anti-GAP45 antibodies. ALIX recruitment was assessed over 50 invading
parasites. Results are presented as mean ± SD of three independent replicates. P
values reported are from two-way ANOVA statistical analysis followed by Tukey’s
multiple comparison. Pixel intensity at the site of ALIX recruitment was normal-
ized to the background fluorescence in the HeLa cytoplasm. The pixel intensity of
thirty ALIX dots were quantified per experiment and results are presented as mean
± SD of three independent replicates. P values reported are from two-way ANOVA
statistical analysis followed by Tukey’s multiple comparison on GraphPad Prism
8 software.
Topology. To assess RON13 topology, we used GFP nanobodies (kind gift from
Clare Harding)37. Briefly, 2 × 106 RH (negative control), ARO-YFP, and RON11-
YFP (positive controls) and RON13-YFP parasites were transiently transfected with
30 µg of mCherry-GFP nanobodies-DD plasmid and used to infect an HFF
monolayer. The day after, 1 µM of Shield was added to the infected cells for 1 h
prior to methanol fixation and immunofluorescence assay using anti-myc and anti-
GFP antibodies. This experiment was done in triplicate.
Solubility test. To assess the solubility of RON13, extracellular parasites ASP3-
iKD/RON13-3Ty from culture pretreated ±ATc for 48 h, were pelleted and
resuspended in PBS or PBS-2% TX-100. Samples were lysed by freeze-thawing and
incubated at 37 °C. The pellet and the soluble fraction were separated by cen-
trifugation for 30 min at 4 °C max and 15,000 × g. Samples were finally resuspended
with SDS–PAGE loading buffer (±10 mM DTT) and heated at 95 °C for 10 min
prior to separation. This experiment was done in triplicate.
Beta-lactamase assay. The activity of the beta-lactamase fusion proteins was
assessed on extracellular parasites. Extracellular parasites from RH, toxofilin-BLA,
and RON13-BLA strains were washed twice in PBS and incubated with the BLA
substrate CCF4-AM (Thermo Fisher Scientific) or DMSO (control) in DMEM, 5%
FCS for 2 h in the dark at room temperature, according to manufacturer’s protocol.
Following two washes in PBS, extracellular parasites were distributed in a 96-well
plate and the fluorescence at 450 and 550 nm (excitation 405 nm) was read on a
SpectraMax Paradigm reader (Molecular Devices,LLC) at the READS platform of
the University of Geneva. The experiment was performed in three independent
experiments. The relative fluorescence was obtained by subtracting the background
fluorescence (DMSO wells) to the absolute fluorescence (CCF4-AM wells).
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Analysis of rhoptry protein secretion into the host cell was assessed by flow
cytometry by detection of beta-lactamase activity in the host cell16. HFF
monolayers were infected with extracellular parasites from RH, toxofilin-BLA, and
RON13-BLA parasites at a MOI of 30. After 1 h, cells were washed and incubated
with the BLA substrate CCF4-AM (Thermo Fisher Scientific) or DMSO (control)
for 2 h in the dark at room temperature. Cells were washed three times with PBS,
trypsinised and analyzed by flow cytometry on a Gallios flow cytometer (Beckman
Coulter) at the flow cytometry platform (University of Geneva, Switzerland).
Samples were excited at 405 nm and coumarin and fluorescein were detected with
the 450/50 nm laser and the 550/40 nm laser, respectively. FlowJo (Becton,
Dickinson & Company) and Kaluza (Beckman Coulter) softwares were used for
analysis. Graphs were made using GaphPad Prism 8 and represent means ± SD
from three independent assays. Statistical significance was assessed by a paired
t test.
Kinetic assay measuring host cell impedance. Host cell damage following
infection was assessed by the Live Cell Analysis System xCELLigence (OLS®) that
measure cellular impedance in a kinetic assay and collected on the RTCA software
(Agilent, version 1.0). HFF (5 × 104 cells) were seeded in an eight-well E-plate and
cellular impedance was measured every 30 min during 24 h. The next day, medium
was renewed 2 h prior infection. HFF were infected with 5 × 105 freshly egressed
parasites, the plate was centrifuged 1 min at 2500 × g and put back in the xCEL-
Ligence. Extracellular parasites were washed away 30 min post infection and cel-
lular impedance was measured every 30 min during 60 h. Data were normalized
according to the cellular impedance at the time of the last wash, and expressed as a
percentage of the impedance measured for uninfected wells overtime. Three
independent experiments were done in duplicate.
Animal experimentation. Virulence assays were performed by intraperitoneal
injection of 100 freshly lysed tachyzoites (RH and mutant strains) in 7-week-old
female CD1 mice (Charles River). Mice were monitored daily and sacrificed at the
onset of signs of acute infection (ruffled fur, difficulty moving, and isolation).
Surviving mice were assessed for seroconversion by Western blotting, as well as
challenged with an inoculation with 1000 freshly lysed RH tachyzoites at 84 days
post infection. Surviving mice were humanely sacrificed at the end of the experi-
ment, ~40 days after the challenge infection.
Ethics statement. All animal experiments were conducted with the authorization
numbers GE121-19, according to the guidelines and regulations issued by the Swiss
Federal Veterinary Office. All animals were housed at the University of Geneva in
room with day/night cycle of 12 h/12 h and constant ambient temperature of 22 °C
and 35% humidity, respectively.
Transmission electron microscopy (TEM). Infected HFF cells grown on a round
glass coverslips were fixed with 2.5% glutaraldehyde (Electron Microscopy Sci-
ences) and 2% PFA (Electron Microscopy Sciences) in 0.1 M sodium cacodylate
buffer at pH 7.4 for 1 h at room temperature. Traces of fixative were removed by
extensive washing with 0.1 M sodium cacodylate buffer, pH 7.4, and postfixed with
reduced 1% osmium tetroxide (Electron Microscopy Sciences) with 1.5% potassium
ferrocyanide in 0.1 M sodium cacodylate buffer, pH 7.4 for 1 h and immediately
followed by 1% osmium tetroxide alone (Electron Microscopy Sciences) in the
same buffer for 1 h. After two washes in double-distilled water (ddH20) for 5 min
each wash samples were en bloc stained with aqueous 1% uranyl acetate (Electron
Microscopy Sciences) for 1 h or overnight at 4 °C. After a 5 min wash in ddH20,
cells were dehydrated in graded ethanol series (2× 50, 70, 90, 95%, and 2× absolute
ethanol) for 10 min each wash and infiltrated with graded series of Durcupan resin
(Electron Microscopy Sciences) diluted with ethanol at 1:2, 1:1, and 2:1 for 30 min
each. Next, cells were infiltrated twice with pure Durcupan for 30 min each and
with fresh Durcupan resin for additional 2 h. Finally, coverslips with cells facing
down, were placed on 1 mm thick teflon rings filled with resin and placed on glass
slide coated with mold separating agent (Glorex) and polymerized in the oven at
65 °C for 24 h. The glass coverslip was removed from the cured resin disk by
alternate immersion into hot (60 °C) water and liquid nitrogen, until the glass
parted. Laser microdissection microscope (Leica Microsystems) was used to select
suitable areas and to outline their positions on the resin surface to cut out from the
disk using a single-edged razor blade and glued with superglue (Ted Pella) to a
blank resin block. The cutting face was trimmed using a Leica Ultracut UCT
microtome (Leica Microsystems) and a glass knife. A 70 nm ultrathin serial sec-
tions were cut with a diamond knife (DiATOME) and collected onto 2 mm single
slot copper grids (Synaptec, Ted Pella) coated with Formvar plastic support film.
Sections were examined using a Tecnai 20 TEM (FEI) operating at an
acceleration voltage of 80 kV and equipped with a side-mounted MegaView III
CCD camera (Olympus Soft-Imaging Systems) controlled by iTEM acquisition
software (Olympus Soft-Imaging Systems).
FIB-SEM and 3D reconstruction. Sample for FIB-SEM imaging were prepared in
the same way as for the TEM. Selected parasitophorous vacuoles were marked on
the surface of the resin block by laser microdissection microscope (Leica Micro-
systems). Either whole resin block or large cut out area containing the region of
interest was glued onto a flat SEM stub with superglue, and silver conductive paste
was applied on each side of the resin block to ensure the conductivity within SEM.
Finally, the mounted sample was gold coated with 20 nm thick layer of gold.
The samples were imaged inside a FEI Helios NanoLab G3 UC DualBeam
microscope (FEI). Ion beam was used in conjunction with a gas injection system to
deposit a thick (∼1.5 µm) layer of platinum on the top surface of the sample above
the region of interest to reduce the FIB milling artefacts. The imaging surface was
exposed by creating the front trench using 21 nA of focused ion beam current at 30
kV voltage and subsequently two side trenches were created using the same
parameters. AutoSlice and View G3 software (FEI) was used to acquire the serial
SEM images. Focused ion beam at current of 2.5 pA and 30 kV of acceleration
voltage was applied to mill 10 nm layer from imaging face, and freshly exposed
surface was imaged with back scattered electron beam at current of 400 pA and at
acceleration voltage of 2 kV, the dwell time of 9 µs/pixel and at the resolution of 4
nm/pixel. Serial images were combined into single image stack, aligned, and scaled
down to obtain imaged volume with isotropic pixel properties of the 10 nm/pixel in
all x-, y-, and z-dimension using the FIJI program (fiji.sc/). Semiautomated
approach using Ilastik software (ilastik.org) was used for segmentation and 3D
reconstruction. Final 3D models were visualized using the Blender software (v.2.79;
blender.org).
Image acquisition. Confocal images were acquired with a confocal laser scanning
microscope LSM700 (Zeiss) and confocal expansion microscopy images were
collected with a TCS SP8 STED ×3 microscope (Leica) at the Bioimaging Core
Facility of the University of Geneva Medicine Faculty. Image processing for
expansion microscopy was performed using LasX Software (Leica, version 3.7.0),
while ImageJ (NIH; version 1.53c) was used otherwise. The antibodies used for
immunofluorescence assay and their dilutions are listed in Supplementary Table 6.
Secondary antibodies were purchased from Invitrogen® and used according to the
manufacturer’s protocol.
Ultrastructure expansion microscopy. U-ExM was performed on extracellular
parasites38. Extracellular parasites were resuspended in PBS and settled on a poly-
D-lysine (Gibco) coated 12 mm coverslip. Protein crosslinking was performed by
incubating the coverslip in 1.4% formaldehyde/2% acrylamide/PBS solution for 5 h
at 37 °C. The monomer solution (19% sodium acrylate (Sigma)/10% acrylamide
(Sigma)/0.1% N, N′-methylenbisacrylamide (Sigma)/PBS), as well as the 10%
TEMED and 10% APS solutions were thawed on ice. The gelation step was per-
formed on ice as well with the coverslip incubated face down on a drop of 35uL of
the gelation solution (90 µL monomer solution+ 5 µL TEMED 10%+ 5 µL APS
10%) in a humid chamber for 5 min followed by an incubation at 37 °C for 1 h. The
gel and coverslip were then transferred to six-well plate filled with denaturation
buffer (200 mM SDS, 200 mM NaCl, and 50 mM Tris pH 9.0) face up for 15 min at
room temperature under agitation. When the gel detached from the coverslip, it
was transferred into a Eppendorf filled with denaturation buffer and incubated at
95 °C for 1.5 h. A first round of expansion was performed by incubating the gel
three times in ddH20 for 30 min. Prior incubation with the primary antibodies
diluted in Tween 0.1%/PBS for 3 h at 37 °C, two rounds of gel shrinkage were
performed by replacing the ddH2O with PBS for 15 min. Following three washes of
10 min each in Tween 0.1% / PBS, secondary antibody detection was performed. A
last round of expansion was done by incubating the gel for 30 min twice in ddH2O
and then overnight. For imaging, pieces of gel were put on poly-D-lysine (Gibco)
coated 24 mm coverslip with sample facing down clipped on 35 mm round
adapters (Okolab). Images were acquired on a Leica Thunder inverted microscope
using 63× 1.4 NA oil objective with Small Volume Computational Clearing mode
to obtained deconvolved images. 3D stacks were acquired. Images were analyzed
and merged using LasX software (Leica).
The antibodies used and the appropriate dilution are mentioned in
Supplementary Table 6.
Phylogeny. Sequences of Apicomplexan kinases were procured from EuPathDB
and aligned using MUSCLE sequence alignment software (version 3.8.31)39. The
resulting sequence alignment was manually curated utilizing BioEdit (http://www.
mbio.ncsu.edu/bioedit/bioedit.html) to edit out uninformative alignment positions.
Phylogeny tree was generating utilizing PhyML (version 3.0)40 on the curated
MUSCLE alignment. The curated alignment of sequences used in the phylogenetic
analysis can be found in Supplementary Data 8.
RON13 purification for antibody generation. The RON13 kinase domain
(163–769) was inserted into a pGEX-modified vector to contain a N-terminal
His10-tag followed by a tobacco etch virus (TEV) protease recognition site (Gib-
son; digested with NotI/KpnI). The plasmid was transformed into Rosetta DE3
pLysS cells and cultures were grown until reaching an OD600 of 0.6. Protein
production was induced by adding IPTG to a final concentration of 0.5 mM and
left to incubate for 4 h at 37 °C. Cells were then harvested by centrifugation at
4000 × g for 15 min and the pellet was frozen at −80 °C. The pellet from 1 L of cells
was resuspended in 25 mL of bacteria lysis buffer (50 mM Tris pH 8, 400 mM
NaCl, 15 mM imidazole, 0.05 % Triton X-100, 8 M urea, and 3 mM beta-
mercaptoethnol (2-ME)). Cells were lysed by two passages through a French
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Pressure Cell at 1000 p.s.i. Cell membranes and debris were removed by cen-
trifugation at 35,000 × g for 30 min at 4 °C. The supernatant containing soluble
proteins was applied to a 5 mL His-trap FF column (GE healthcare), washed with
50 mL of lysis B buffer, followed by a second washing step using bacteria Ni-A
buffer (15 mM Tris pH 8, 200 mM NaCl, 15 mM imidazole, 5 M urea, and 3 mM 2-
ME). Protein was then eluted using bacteria Ni-A buffer supplemented with 430
mM imidazole. Eluted proteins were concentrated to 1 mg/mL using AMICON 30
MWCO concentrators and used as antigens for antibodies generation at the
Geneva Antibody Facility (University of Geneva, Switzerland).
ASP3 purification from insect cells. Recombinant ASP3 protease was expressed
in baculovirus-infected Sf9 insect cells. Baculovirus were generated using a mod-
ified pFastBac vector encoding a N-terminal Melittin secretion signal, followed by
ASP3 protease (TGME49_ 246550, amino acids 38–643) and a C-terminal His6
tag. Cells infected for 68 h were harvested by centrifugation at 4000 × g for 15 min
at 4 °C. The pellet was dissolved in Asp3 lysis buffer (50 mM Tris-HCl pH 8, 500
mM NaCl, 10 mM imidazole, 0.1% Triton X-100, and 3 mM 2-ME) and lysed by
one passage through a French Pressure Cell at 1500 p.s.i. Cell membranes and
debris were removed by centrifugation of the lysate at 35,000 × g for 35 min at 4 °C.
The supernatant containing soluble protein was applied to a 5 mL His-trap column
(GE healthcare), washed with 40 mL of Asp3 lysis buffer and with 40 mL of Asp3
Ni-A buffer (20 mM Tris pH 8, 150 mM NaCl, 15 mM imidazole, and 3 mM 2-
ME). Protein was eluted with 15 mL of Asp3 Ni-B buffer (20 mM Tris pH 8, 150
mM NaCl, 350 mM imidazole, and 3 mM 2-ME). Eluted protein was diluted
fivefold with Asp3 Q-A buffer (20 mM Tris pH 8, 10 mM NaCl, and 3 mM 2-ME)
and loaded to a 5 mL Q-HP column (GE healthcare). The protein was eluted by
applying a gradient from 10 to 30% Asp3 Q-B buffer (20 mM Tris pH 8, 1 M NaCl,
and 3 mM 2-ME) in 40 mL. Fractions containing ASP3 protein were pooled,
concentrated to 1 mL using AMICON 30 MWCO concentrators, and loaded on a
size-exclusion Superdex 200 10/300 column at 4 °C equilibrated in Asp3 final
buffer (50 mM Hepes pH 7.4/150 mM KCl, 5% glycerol, and 1 mM DTT). Frac-
tions containing pure ASP3 were pooled, concentrated to 1 mg/mL and flash frozen
in liquid nitrogen.
Recombinant RON13 purification. All RON13 constructs and mutants used for
structural and biochemical studies were expressed in insect cells and purified,
following the same procedure. RON13 coding sequence (amino acids 271–1375)
was inserted into a modified pFastBac vector encoding a N-terminal Melittin
secretion signal, a GST-tag and a TEV recognition site preceding RON13, and a C-
terminal 10-His tag. Proteins were expressed in baculovirus-infected Sf9 cells for
66 h at 27 °C before cell harvesting and purification. The pellet from 1 L of cells was
resuspended in 60 mL of Sf9 lysis buffer (50 mM Tris-HCl pH 7.5, 300 mM NaCl,
5 mM EDTA, and 3 mM 2-ME) containing protease inhibitors and lysed by one
passage through a French Pressure Cell at 1500 p.s.i. Cell membranes and debris
were removed by centrifugation at 35,000 × g for 30 min at 4 °C and soluble pro-
teins were applied to 5 mL (bed volume) of gluthatione-agarose resin equilibrated
in Sf9 lysis buffer. The sample was incubated for 4 h at 4 °C on a roller, then
transferred to a gravity purification column to remove unbound material. The resin
was washed with 50 mL of Sf9 lysis buffer followed by another 50 mL wash with Sf9
wash buffer (20 mM Tris pH 7.5, 100 mM NaCl, 0.5 mM EDTA, and 3 mM 2-ME).
On-resin digestion was performed to elute the untagged RON13 protein from the
resin. For this, 400 µg of pure TEV protease was diluted in 5 mL of Sf9 wash buffer
and applied to the resin. After 2 h incubation at 22 °C, the digested protein was
eluted by applying twice 7 mL of Sf9 wash buffer. The TEV protease was separated
from RON13 using an anion-exchange column. Proteins eluted were concentrated
to 3 mL using AMICON 30 MWCO concentrators, diluted fourfold with a 100 mM
Tris-HCl pH 8 solution, and passed through a 1 mL Q-XL column (GE healthcare).
The unbound material, containing RON13, was concentrated to 1 mL using
AMICON 30 MWCO concentrator and loaded on a Superdex 200 10/300 size-
exclusion chromatography column equilibrated in Sf9 final buffer (5 mM Tris-HCl
pH 7.5/200 mM NaCl/0.5 mM EDTA/3 mM DTT). Fractions containing pure
RON13 protein, eluting ~13 mL, were pooled, concentrated, and flash frozen in
liquid nitrogen before storage at −80 °C.
Recombinant dephosphorylated RON4 purification. RON4 FL (gene
TGGT1_229010 product, residues 27–984) purification was performed using Ni2+
metal affinity purification5. Sequence of RON4 (27–984) with a C-terminal His6 tag
was inserted into a modified pFastBac vector encoding a N-terminal gp67 secretion
signal. Baculoviruses encoding RON4 protein were generated following standard
procedures. Briefly, a pellet of Sf9 cells infected for 70 h was resuspended in lysis
buffer 4 (50 mM Tris pH 8, 500 mM NaCl, 20 mM imidazole, and 3 mM 2-ME),
lysed by shear forces at 15,000 p.s.i. using a Microfluidizer instrument. Cell
membranes and debris were removed by centrifugation at 35,000 × g for 30 min at
4 °C, and soluble proteins were passed through a 5 mL His-trap FF column, washed
with 50 mL of lysis buffer 4, and eluted with 15 mL of lysis buffer 4 supplemented
with 350 mM imidazole. The protein was dephosphorylated using 400 units of
alkaline phosphatase (CIAP, Promega # M1821A, 1 U/μL) in a buffer supple-
mented with 10 mM MgCl2 prior to running a Superdex 200 size-exclusion
chromatography step equilibrated in SEC buffer 4 (25 mM Tris pH 7.5, 150 mM
NaCl, and 0.5 mM EDTA) to separate RON4 protein from the phosphatase.
Radioactive kinase assays. RON13 in vitro kinase activity was measured by
looking at the transfer of γ-32P from ATP to substrate proteins. Reactions were run
in 15 μL volume with a final RON13 concentration of 50 nM in kinase reaction
buffer (20 mM Tris pH 7.5/50 mM NaCl/0.5 mM EDTA/0.5 mM EGTA). Reactions
were supplemented with 6 mM of metal ion cofactor (MgCl2 for Mg2+, CaCl2 for
Ca2+, and MnCl2 for Mn2+). Substrates were used at a final 1.5 μM concentration
(MBP, dephosphorylated, Millipore #13-110). Reactions were initiated by the
addition of tenfold concentrated ATP (100 μM final) containing 5 μCi of ATP-γ
−32P. Reactions were run for 5 min at 37 °C. Phosphotransfer activity was mon-
itored by analyzing 5 μL of reaction sample on a SDS–PAGE and the amount of
protein phosphorylation was determined by exposing the gel to a X-ray sensitive
plate. ATPase activity was measured by spotting 1 μL of reaction onto a TLC plate.
ATP was separated from free phosphate by migrating the silica plate using a
solution of 1 N formic acid/0.5 N LiCl as eluent. Exposure to an X-ray sensitive
plate was used to measured radioactive 32P on a Typhoon instrument (GE
healthcare). Experiments were done in triplicate.
Hydrogen/deuterium exchange coupled to mass spectrometry. HDX-MS
experiments were performed at the UniGe Protein Platform (University of Geneva,
Switzerland) following a well-established protocol with minimal modifications41.
HDX reactions were done in 50 μL volumes using 60 pmol (1.3 μM) of rRON13dk
and a threefold molar excess of recombinant RON4. Briefly, rRON13dk was pre-
incubated with buffer (RON13-alone) or RON4 on ice in a final volume of 7.7 μL.
The mix was then left to equilibrate at the room temperature for 10 min. Deu-
terium exchange reactions were initiated by adding 42.3 µL of D2O exchange buffer
(96% D2O, 10 mM HEPES pH 7.5, 100 mM NaCl, and 0.5 mM EDTA) to the
rRON13 protein mixture. Reactions were carried-out for 3, 30, and 300 s at room
temperature, and terminated by the sequential addition of 20 μL of ice-cold
quenching buffer 1 (6 M urea/0.1 M NaH2PO4 pH 2.5/1% formic acid). Samples
were immediately frozen in liquid nitrogen and stored at −80 °C for up to 4 weeks.
All experiments were repeated in triplicates.
To quantify deuterium uptake, protein samples were thawed and injected in
UPLC system immersed in ice. The protein was digested via two immobilized
pepsin columns (Thermo #23131), and peptides were collected onto a VanGuard
pre-column trap (Waters). The trap was subsequently eluted and peptides
separated with a C18, 300 Å, 1.7 μm particle size Fortis Bio column 100 × 2.1 mm
over a gradient of 8–30% buffer B over 20 min at 150 μL/min (buffer A: 0.1%
formic acid; buffer B: 100% AcN). Mass spectra were acquired on an Orbitrap
Velos Pro (Thermoscientific), for ions from 400 to 2200m/z using an electrospray
ionization (ESI) source operated at 300 °C, 5 kV of ion spray voltage. Peptides
identified by data-dependent acquisition after MS/MS and data were analyzed by
Mascot. A 94% sequence coverage was obtained. Deuterium incorporation levels
were quantified using HD examiner software version 1.4 (Sierra Analytics), and
quality of every peptide was checked manually. Results are presented as percentage
of theoretical maximal deuteration level and can be compared to a highly-
deuterated sample that was prepared by incubating the protein for 1 h in 1 M
guanidinium-HCl before incubation for 2 h in deuterated buffer. All experimental
details and data of percentage deuterium incorporation for all peptides can be
found in Supplementary Table 3 and Supplementary Data 6. The HDX-MS data
have been deposited on the ProteomeXchange Consortium via the PRIDE42
partner repository with the dataset identifier PXD023791.
Cryo-EM sample preparation and data collection. The purified RON13-KD was
concentrated (15 mg/mL) and immediately used for cryo-EM grid preparation. For
cryo-EM sample preparation, Quantifoil 1.2/1.3 200-mesh grids were glow dis-
charged using a PELCO easiGlow (Ted Pella) for 30 s at 25 mA in air. An aliquot of
the protein (3.5 µL) was deposited on the surface of the grid immediately before
blotting for 3 s on a Vitrobot Mark IV (FEI) operating at 4 °C with 100% humidity
(blot force 0) and plunging the grid into liquid ethane. The grids were transferred
into liquid nitrogen for storage until the day of cryo-EM data collection. A cryo-
EM dataset was collected at using Titan Krios microscope equipped with a Gatan
K2 Summit detector and an energy filter at ETH Zurich (ScopeM). The dataset was
collected in counting mode using EPU, at a magnification of 165,000×, corre-
sponding to a pixel size 0.8544 Å/pix. The exposure was 8 s over 40 frames, with a
total dose of 47 e−/Å2.
Cryo-EM data analysis. Motion correction and alignment of the cryo-EM movies
was performed using MotionCor2 (UCSF; version 1.3.0)43; the defocus of the
aligned micrographs was estimated using Gctf (version 1.06)44. The images with an
estimated resolution higher than 4.5 Å (4782 micrographs) were used in the further
processing steps; all subsequent steps were performed in relion-3.0 (refs. 45,46).
Manual particle picking and 2D classification of a small subset of particles (732)
was used to generate four autopicking templates. In total 1,385,124 particles were
autopicked and extracted from the selected micrographs (downsampled to 2.56 Å/
pix in a 100 pix box). Two rounds of 2D classification produced 2D classes with
clearly visible secondary structure elements (711,852 particles). An initial model
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generated using this particle selection in relion-3.0 was used for 3D classification. A
round of 3D classification with four classes (T= 4, E= 8, mask 190 Å) produced a
single class (348,152 particles) was followed by a round of masked 3D classification
without alignment (T= 4, E=−1) generating a 3D class used for further pro-
cessing (320,723 particles). The particles constituting this 3D class were used in 3D
refinement (3.4 Å resolution, FSC cutoff 0.143). Further CTF refinement and
Bayesian particle polishing, followed by 3D refinement and a post-processing step
(applying a b-factor of −85.7 estimated in relion-3.0), produced the final map 3.1 Å
resolution. The local resolution of the map was estimated in relion-3.0. The ani-
sotropy of the cryo-EM map was assessed using the 3DFSC server47. Slight ani-
sotropy was detected (Supplementary Fig. 4i), without a substantial effect on the
quality of the density map (global resolution reported by 3DFSC is 3.09 Å, con-
sistent with the results of Relion processing). The complete cryo-EM data analysis
procedure is illustrated in Supplementary Fig. 4.
Model building and validation. An initial round of autobuilding was performed
using phenix.map_to_model (Phenix 1.16-3549)48. All subsequent model building
steps were performed in Coot (version 0.9.5)49 using the 3.1 Å post-processed map.
The atomic model of RON13-KD was refined using phenix.real_space_refine in
Phenix (version 1.16-3549). For model validation, the atom coordinates in the
refined model were randomLy displaced by a 0.5 Å using the PDB tools in Phenix
and the derived model was subjected to real space refinement using one of the
refined half maps (half-map1). Map versus model FSC comparison was made for
the model against the corresponding half-map1 used in the refinement job, and for
the same model versus the half-map2 (not used during refinement)50. The geo-
metry of the model was validated using MolProbity (version 4.5.1)51. Figure panels
featuring the density maps and structural models were prepared using PyMol
(DeLano Scientific LLC, version 4.2.4)52 and UCSF Chimera53 (UCSF; version
1.13.1).
Phosphoproteome sample preparation. T. gondii tachyzoites were cultured using
HFFs as host cells. After 48 h, the supernatant was removed and syringe homo-
genized prior to differential centrifugation at 200 × g for 5 min to pellet host cells.
The supernatant containing extracellular parasites was filtered to remove cell debris
and the parasites were washed five times in PBS containing protease inhibitors.
Samples were prepared for each strain from four independent experiments. Pro-
teins were extracted from tachyzoites in 4% SDS/0.1 M DTT/100 mM Tris-Cl pH
8.2 first by boiling at 95 °C for 5–10 min and following by at least one round of
exposure to high-intensity focused ultrasound for 1 min at 100% amplitude and
80% duty cycle. Insoluble material was pelleted by high-speed centrifugation and
190–300 µg of proteins in 60 µL of 4% SDS/0.1 M DTT/100 mM Tris-Cl pH 8.2
were further processed using a modified protocol for filter-aided sample
preparation54. A total of 400 µL of 8 M urea/100 mM Tris-Cl pH 8.2 were added,
and the sample was loaded onto a Microcon-30kDa Centrifugal Filter Unit (Merck)
and centrifuged at 14,000 × g until ~10 µL remained. The sample was washed with
200 µL 8M urea/100 mM Tris-Cl pH 8.2 and subsequently, 100 µL 50 mM
iodoacetamide/8 M urea/100 mM Tris-Cl pH 8.2 was added. The solution was
shaken at 600 r.p.m. for 1 min and incubated for 5 min at RT. The sample was spun
at 14,000 × g and washed three times with 100 µL 8M urea/100 mM Tris-Cl pH 8.2.
The sample was then washed twice with 50 mM of triethylammoniumbicarbonate
(TEAB) in H2O and spun at 14,000 × g. A total of 120 µL of trypsin in 50 mM
TEAB at 1/50 w/w was added to the sample, mixed at 600 r.p.m. for 1 min, and
incubated in a wet chamber overnight. Peptides were collected by centrifugation at
14,000 × g, a 5 µL aliquot was removed as input sample and the peptides con-
centrated by vacuum centrifugation. For the following steps, all the incubation
steps were done while shaking at 700 r.p.m. at RT and supernatants removed after
bead attachment to a magnet. A 50 µL of Ti-IMAC beads (ReSyn Biosciences) per
sample were washed twice with 200 µL 70% ethanol for 5 min, and subsequently
once with 100 µL 1% NH4OH 10min. Beads were equilibrated three times for 1
min in 50 µL loading buffer (380 mg glycolic acid/5% trifluoroacetic acid (TFA)/
80% AcN). Peptides were taken up in 100 µL loading buffer and incubated 20 min.
Beads were washed in 100 µL loading buffer for 30 s and washed three times with
100 µL 1% TFA/80% AcN for 2 min, and then twice with 0.2% TFA/10% AcN for 2
min. Phosphopeptides were eluted three times in 80 µL 1% NH4OH for 15 min.
Samples were vacuum dried and resuspended in 15 µL 0.1% formic acid/3% AcN.
To the input sample, 10 µL 0.1% formic acid/3% AcN was added.
Reverse phase chromatography and mass spectrometry. For peptide separation
by reverse phase chromatography, a Waters ACQUITY UPLC M-Class was used
with a 20 mm nanoEase M/Z Symmetry C18 trap column (180 µm inner diameter
packed with 5 µm C18 silica particles), and a 25 cm nanoEase M/Z HSS C18 T3
column (75 µm inner diameter and packed with 1.8 µm C18 silica particles), and
analytical column. Total separation time was 75 min over a linear gradient from 5
to 35% solvent B (solvent A: 0.1% formic acid in H2O, solvent B: 0.1% formic acid
in AcN) with a flow rate of 300 nL/min. Separated peptides were directly applied by
ESI into an Orbitrap Q-Exactive HF mass spectrometer (Thermo Fisher Scientific).
The mass spectrometry was set up in full MS/data-dependent-MS2 mode. For the
full scans, a scan range of 350–1500m/z at a resolution of 120,000 was used with an
automatic gain control (AGC) target at 3 × 10e6 and a maximum injection time of
50 ms. The top 20 most intense ions were isolated with a maximum injection time
of 119 ms, fragmented with a NCE of 28 and detected at 60,000 resolution with a
scan range of 200–2000m/z and an AGC target of 1 × 10e5 (fixed first mass 130
m/z).
Phosphoproteome data analysis. Individual data analysis workflows have been
used for global protein and phosphopeptide analysis. The statistical analysis was
done in a two-group comparison, i.e., RON13-KD versus RH and RON13-KD
complemented with WT RON13 versus RON13-KD complemented with inactive
RON13. For proteome and phosphoproteome, the acquired raw MS data were
processed by MaxQuant (version 1.6.2.3), followed by protein identification using
the integrated Andromeda search engine55. Spectra were searched against the
ToxoDB GT1 protein database (release 44), concatenated to its reversed decoyed
fasta database and common protein contaminants. By default, carbamidomethy-
lation of cysteine was set as fixed modification, while methionine oxidation and N-
terminal protein acetylation were set as variable. In addition, Phospho(STY) was
set as a variable modification. Enzyme specificity was set to trypsin/P allowing a
minimal peptide length of seven amino acids and a maximum of two missed-
cleavages. For the proteome data, MaxQuant default search settings for Orbitrap
were used. The maximum FDR was set to 0.01 for peptides and 0.05 for proteins.
Label-free quantification was enabled and a 2 min window for match between runs
was applied. In the MaxQuant experimental design, each file is kept separate to
obtain individual quantitative values. Protein fold changes were computed based on
intensity values reported in the proteinGroups.txt file. A set of functions imple-
mented in the R package SRMService56,57 was used to filter for proteins with two or
more peptides allowing for a maximum of four missing values, normalizing the
data with a modified robust z-score transformation and computing P values using
the moderated t test with pooled variance (as implemented in the limma
package58). If all measurements of a protein are missing in one of the conditions, a
pseudo fold change was computed replacing the missing group average by the
mean of 10% smallest protein intensities in that condition. For the phosphopro-
teome data, each file was kept separate in the experimental design to obtain
individual quantitative values. Precursor and fragment tolerance was set to 10 and
20 p.p.m., respectively for the initial search. The maximum FDR was set to 0.01 for
peptides and 0.05 for proteins. Label-free quantification was enabled and a 2 min
window for match between runs was applied. The re-quantify option was selected.
For the phosphosite analysis, a similar data analysis strategy as described by
Sharma et al.59 was implemented. In brief, the MaxQuant phospho_STY_site.txt
file was used as the input file. The phosphosite table was expanded with respect to
their multiplicity and filtered for a minimum localization site probability of 0.75.
For each two-group comparison, all peptides with a maximum of four missing
values were retained. The data (like for the total proteome) was normalized with a
modified robust z-score transformation and P values were computed with a
moderated t test with pooled variance (as implemented in the limma package58). If
all measurements of a protein were missing in one of the conditions, a pseudo fold
change was computed replacing the missing group average by the mean of 10%
smallest protein intensities in that condition. Calculated P values are adjusted for
multiple testing using the BH-method. The statistics of the phosphopeptide
analysis and the total proteome analysis were merged. The mass spectrometry
proteomics data have been deposited to the ProteomeXchange Consortium via the
PRIDE36 partner repository with the dataset identifier PXD018056.
Data parsing and analysis. For comparison to the existing phosphoproteome13,
phosphopeptide data from all strains in this study, and data from purified tachy-
zoites and infected host cells (phosphopeptide-enriched and -depleted) were
pooled. The ToxoDB gene IDs, as well as phosphosites from each study were then
intersected and plotted as a Venn diagram. To identify potential targets of RON13,
the comparison of RON13-KD to RH (dataset 1), as well as of RON13-KD/ron13wt
and RON13-KD/ron13dk (dataset 2) were used. Peptide contaminants and pep-
tides mapping to reverse proteins were removed. Phosphopeptides with at least
fourfold more abundance in either comparison (log2FC <−2) were selected for
further analysis. Peptides with the posterior error probabilities (PEPs) > 0.05 and
with P values (associated to the log2FC) were >0.05 were excluded. The common
hits between both datasets were then considered high-confidence candidates of
RON13. Differences in multiplicity of phosphorylation were not taken into account
if position of the phosphorylated amino acid was identical. The polar plot was built
by slightly modifying the R package funscoR (https://github.com/evocellnet/
funscoR)60. The phosphoproteome data have been deposited on the Proteo-
meXchange Consortium via the PRIDE42 partner repository with the dataset
identifier PXD018056.
Determination of phosphoserine sequence logo. To determine the sequence
logos for phosphoserine, the phosphopeptides corresponding to RON13 substrates
(Supplementary Data 5) containing phosphoserines were used. The flanking 15
amino acids of the phosphoserines were extracted, and the resulting 31 amino acid
sequences were used as an input for Sequence Logo Analysis tool at
PhosphoSitePlus61 (www.phosphosite.org, version 6.5.9.3). PSP production was
used as an algorithm and “Phoshpo Ser” used as background. The consensus
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sequence was computed using EMBOSS62 (https://www.ebi.ac.uk/Tools/msa/
emboss_cons/).
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
All data are present in the main text and the supplementary materials. The mass
spectrometry proteomics regarding RON4 immunoprecipitation have been deposited on
the ProteomeXchange Consortium via the PRIDE42 partner repository with the dataset
identifier PXD021516. The phosphoproteomic data have been deposited on the
ProteomeXchange Consortium via the PRIDE42 partner repository with the dataset
identifier PXD018056. The HDX-MS data have been deposited on the ProteomeXchange
Consortium via the PRIDE42 partner repository with the dataset identifier PXD023791.
The coordinates and the cryo-EM map have been deposited to the Protein Data Bank
(PDB ID: 7NUR) and Electron Microscopy Data Bank (accession code: EMD-12600).
The public dataset used for mass spectrometry analysis of RON4 immunoprecipitation is
the ToxoDB_Tgondii_GT1 database (http://ToxoDB.org, release 42) and the one used
for the phosphoproteomics analysis is the ToxoDB_Tgondii_GT1 database (http://
ToxoDB.org, release 44). All biological materials and data are available from the authors
upon request. Source data are provided with this paper.
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